Targeted therapy for sarcomas.

Biologics · 2014 · PMC3962319 · PMID 24669185

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, the difference in survival did not reach statistical significance; therefore, ridaforolimus did not receive US FDA approval for this setting.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.